文献速递慢性肾脏病

社区人群血浆总脂联素与肾功能变化:DESIR前瞻性队列研究

Plasma total adiponectin and changes in renal function in a cohort from the community: the prospective Data from an Epidemiological Study on the Insulin Resistance Syndrome study.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

该研究基于DESIR前瞻性社区队列,在3284名随机样本中检测血浆脂联素,分析9年随访期间肾功能下降终点。排除基线eGFR<60及随访中出现糖代谢异常者后(n=2174),脂联素最高三分位组较最低三分位组快速肾功能下降风险高113%,KDIGO标准下降风险高53%;横断面分析显示脂联素与基线尿白蛋白/肌酐比值正相关。

要点

  • 社区健康人群中,血浆脂联素升高与基线及随访肾功能下降相关。
  • 脂联素最高三分位组快速肾功能下降风险较最低三分位组高113%。
  • 该关联方向与糖尿病肾病中观察一致,与动物肾病模型相反。

核心结论

  • 在社区健康队列中,较高的血浆脂联素水平与基线和随访时肾功能下降相关。

研究设计与样本

  • DESIR研究为9年前瞻性社区队列,随机样本3284人检测血浆脂联素。
  • 分析排除基线eGFR<60及随访中出现2型糖尿病或空腹血糖受损者,剩余2174人。

主要发现

  • 脂联素高于第三三分位(T3)者较低于第一三分位(T1)者快速肾功能下降风险高113%(Ptrend=0.004)。
  • 脂联素T3组较T1组KDIGO标准肾功能下降风险高53%(Ptrend=0.04)。
  • 横断面分析中,脂联素与基线尿白蛋白/肌酐比值正相关(P=0.009)。

关键数值与推荐

  • 快速肾功能下降定义为eGFR斜率陡于-3 mL/min/1.73 m2/年。
  • KDIGO标准肾功能下降定义为eGFR确定下降。
  • 分期3期CKD为随访终点之一。

临床怎么用

  • 在社区人群中,血浆脂联素升高可能提示肾功能下降风险增加,需关注随访肾功能。
  • 脂联素与尿白蛋白/肌酐比值正相关,或可辅助识别早期肾损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High adiponectin levels are associated with diabetic nephropathy. Nevertheless, it is not known whether plasma adiponectin is associated with renal function decline in the general population. We evaluated whether adiponectin concentrations were associated with changes in renal function in a community cohort, the Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. METHODS: Plasma adiponectin concentrations were measured in a random sample of 3284 people from the DESIR study, a 9-year prospective cohort from the general population. Data were analysed for three endpoints during follow-up: incidence of Stage 3 chronic kidney disease (CKD); the Kidney Disease: Improving Global Outcomes (KDIGO) criterion 'certain drop in eGFR' and rapid kidney function decline [estimated glomerular filtration rate (eGFR) slope steeper than -3 mL/min/1.73 m2/year]. RESULTS: After exclusion of participants with an eGFR <60 mL/min/1.73 m2 at baseline and those with type 2 diabetes or impaired fasting glycaemia at any time during follow-up (remaining n = 2174), there was a 113% higher risk for a rapid decline in kidney function in participants with adiponectin above the third tertile (T3) versus below the first tertile (T1) (Ptrend = 0.004) and a 53% higher risk for kidney function decline as defined by the KDIGO criterion (Ptrend = 0.04). In a cross-sectional analysis, adiponectin was positively associated with urinary albumin:creatinine ratio at baseline (P = 0.009). CONCLUSIONS: In a healthy cohort from the general population, higher levels of plasma adiponectin were associated with decreased renal function at baseline and at follow-up. This result is similar to what is observed in people with diabetic nephropathy, in contrast with animal models of nephropathy.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Fumeron F, El Boustany R, Bastard JP, et al. Plasma total adiponectin and changes in renal function in a cohort from the community: the prospective Data from an Epidemiological Study on the Insulin Resistance Syndrome study. Nephrol Dial Transplant. 2021. PMID: 33141880. doi:10.1093/ndt/gfaa228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。